UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055912
Receipt number R000063886
Scientific Title Carbon-ion radiotherapy for submandibular and sublingual gland carcinomas
Date of disclosure of the study information 2024/10/22
Last modified on 2024/10/22 11:53:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Carbon-ion radiotherapy for submandibular and sublingual gland carcinomas

Acronym

Carbon-ion radiotherapy for submandibular and sublingual gland carcinomas

Scientific Title

Carbon-ion radiotherapy for submandibular and sublingual gland carcinomas

Scientific Title:Acronym

Carbon-ion radiotherapy for submandibular and sublingual gland carcinomas

Region

Japan


Condition

Condition

submandibular and sublingual gland carcinomas

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We will analyze the treatment outcomes of patients with submandibular gland cancer and sublingual gland cancer who underwent carbon-ion radiotherapy at our hospital, and examine its safety and efficacy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Local control, Over all survival, advers events

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Carbon-ion radiaotherapy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with submandibular and sublingual gland cancer who underwent carbon-ion radiation therapy between April 1997 and July 2024.

Key exclusion criteria

Patients who have requested that their data not be used for the purpose of disclosing information about this study.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Hiroaki
Middle name
Last name Ikawa

Organization

National Institutes for Quantum Science and Technology (QST)

Division name

QST Hospital

Zip code

263

Address

4-9-1, Anagawa, Inage, Chiba city, Chiba, Japan

TEL

0432063306

Email

ikawa.hiroaki@qst.go.jp


Public contact

Name of contact person

1st name Hiroaki
Middle name
Last name Ikawa

Organization

National Institutes for Quantum Science and Technology (QST)

Division name

QST Hospital

Zip code

263-8555

Address

4-9-1, Anagawa, Inage, Chiba city, Chiba, Japan

TEL

0432063306

Homepage URL


Email

ikawa.hiroaki@qst.go.jp


Sponsor or person

Institute

National Institutes for Quantum Science and Technology (QST)

Institute

Department

Personal name



Funding Source

Organization

National Institutes for Quantum Science and Technology (QST)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Institutes for Quantum Science and Technology (QST)

Address

4-9-1, Anagawa, Inage, Chiba city, Chiba, Japan

Tel

0432063306

Email

helsinki@qst.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

40

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

1997 Year 04 Month 01 Day

Date of IRB

2024 Year 10 Month 03 Day

Anticipated trial start date

1997 Year 04 Month 01 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 10 Month 22 Day

Last modified on

2024 Year 10 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063886